𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High incidence of mutations inBRCA1 and BRCA2genes in ovarian cancer

✍ Scribed by T. Yu. Smirnova; N. I. Pospekhova; L. N. Lyubchenko; S. A. Tjulandin; R. F. Gar’kavtseva; E. K. Ginter; A. V. Karpukhin


Publisher
Springer US
Year
2007
Tongue
English
Weight
271 KB
Volume
144
Category
Article
ISSN
0007-4888

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Germline mutations in the BRCA1 and BRCA
✍ A. Esra Manguoǧlu; Güven Lüleci; Tayfun Özçelik; Taner Çolak; Hagit Schayek; Mus 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 2 views

In this study we genotyped Turkish breast/ovarian cancer patients for BRCA1/BRCA2 mutations: protein truncation test (PTT) for exon 11 BRCA1 of and, multiplex PCR and denaturing gradient gel electrophoresis (DGGE) for BRCA2, complemented by DNA sequencing. In addition, a modified restriction assay w

BRCA1 and BRCA2 mutations in Turkish fam
✍ Hulya Yazici; Gordon Glendon; Hilal Yazici; Steve J. Burnie; Pánar Saip; Faruk B 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Ovarian cancer is a clinically important cancer in Turkey. The contribution of BRCA1 and BRCA2 to ovarian cancer in Turkish patients has not previously been described. In this study we investigated the presence of BRCA1 and BRCA2 mutations in 102 consecutively ascertained, hospital-based, ovarian ca

Ovarian cancer susceptibility alleles an
✍ Susan J. Ramus; Antonis C. Antoniou; Karoline B. Kuchenbaecker; Penny Soucy; Jon 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB 👁 1 views

Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian cancer. A genome-wide association study (GWAS) identified six alleles associated with risk of ovarian cancer for women in the general population. We evaluated four of these loci as potential modifiers of

Contribution of BRCA1 and BRCA2 mutation
✍ Susan J. Ramus; Patricia A. Harrington; Carole Pye; Richard A. DiCioccio; Mark J 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

A total of 283 epithelial ovarian cancer families from the United Kingdom (UK) and the United States (US) were screened for coding sequence changes and large genomic alterations (rearrangements and deletions) in the BRCA1 and BRCA2 genes. Deleterious BRCA1 mutations were identified in 104 families (